A citation-based method for searching scientific literature

A N Pehlivanidis, V G Athyros, D S Demitriadis, A A Papageorgiou, V J Bouloukos, A G Kontopoulos. Atherosclerosis 2001
Times Cited: 88







List of co-cited articles
515 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity




The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators.
F M Sacks, M A Pfeffer, L A Moye, J L Rouleau, J D Rutherford, T G Cole, L Brown, J W Warnica, J M Arnold, C C Wun,[...]. N Engl J Med 1996
26

Simvastatin normalizes autonomic neural control in experimental heart failure.
Rainer U Pliquett, Kurtis G Cornish, Jacob D Peuler, Irving H Zucker. Circulation 2003
161
23

Lipid lowering drugs and recurrences of life-threatening ventricular arrhythmias in high-risk patients.
J De Sutter, R Tavernier, M De Buyzere, L Jordaens, G De Backer. J Am Coll Cardiol 2000
95
20


Atorvastatin therapy increases heart rate variability, decreases QT variability, and shortens QTc interval duration in patients with advanced chronic heart failure.
Bojan Vrtovec, Renata Okrajsek, Alenka Golicnik, Mateja Ferjan, Vito Starc, Branislav Radovancevic. J Card Fail 2005
81
22


Are lipid-lowering drugs also antiarrhythmic drugs? An analysis of the Antiarrhythmics versus Implantable Defibrillators (AVID) trial.
L Brent Mitchell, Judy L Powell, Anne M Gillis, Victoria Kehl, Alfred P Hallstrom. J Am Coll Cardiol 2003
150
19

HMG-CoA reductase inhibitors improve heart rate variability in patients with a previous myocardial infarction.
Sam Riahi, Jeppe Hagstrup Christensen, Egon Toft, Helle Aarup Skou, Erik Berg Schmidt. Pharmacol Res 2002
19
78

Heart rate variability and plasma lipids in men with and without ischaemic heart disease.
J H Christensen, E Toft, M S Christensen, E B Schmidt. Atherosclerosis 1999
42
33

Lipid lowering by pravastatin increases parasympathetic modulation of heart rate: Galpha(i2), a possible molecular marker for parasympathetic responsiveness.
C Michael Welzig, Dong-Gu Shin, Ho-Jin Park, Young-Jo Kim, J Philip Saul, Jonas B Galper. Circulation 2003
39
35

Reduction in ventricular tachyarrhythmias with statins in the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II.
Anant K Vyas, Hongsheng Guo, Arthur J Moss, Brian Olshansky, Scott A McNitt, W Jackson Hall, Wojciech Zareba, Jonathan S Steinberg, Avi Fischer, Jeremy Ruskin,[...]. J Am Coll Cardiol 2006
128
14

Short-term statin therapy improves cardiac function and symptoms in patients with idiopathic dilated cardiomyopathy.
Koichi Node, Masashi Fujita, Masafumi Kitakaze, Masatsugu Hori, James K Liao. Circulation 2003
338
13

Effects of statin therapy on arrhythmic events and survival in patients with nonischemic dilated cardiomyopathy.
Jeffrey J Goldberger, Haris Subacius, Andi Schaechter, Adam Howard, Ronald Berger, Alaa Shalaby, Joseph Levine, Alan H Kadish. J Am Coll Cardiol 2006
94
13

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group.
J Shepherd, S M Cobbe, I Ford, C G Isles, A R Lorimer, P W MacFarlane, J H McKillop, C J Packard. N Engl J Med 1995
12

Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors.
U Laufs, V La Fata, J Plutzky, J K Liao. Circulation 1998
12

Rosuvastatin decreases caveolin-1 and improves nitric oxide-dependent heart rate and blood pressure variability in apolipoprotein E-/- mice in vivo.
Michel Pelat, Chantal Dessy, Paul Massion, Jean-Pierre Desager, Olivier Feron, Jean-Luc Balligand. Circulation 2003
145
12

Fluvastatin, a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, attenuates left ventricular remodeling and failure after experimental myocardial infarction.
Shunji Hayashidani, Hiroyuki Tsutsui, Tetsuya Shiomi, Nobuhiro Suematsu, Shintaro Kinugawa, Tomomi Ide, Jing Wen, Akira Takeshita. Circulation 2002
264
11

Statin therapy restores sympathovagal balance in experimental heart failure.
Rainer U Pliquett, Kurtis G Cornish, Irving H Zucker. J Appl Physiol (1985) 2003
74
13


Rosuvastatin in older patients with systolic heart failure.
John Kjekshus, Eduard Apetrei, Vivencio Barrios, Michael Böhm, John G F Cleland, Jan H Cornel, Peter Dunselman, Cândida Fonseca, Assen Goudev, Peer Grande,[...]. N Engl J Med 2007
11

Short-term adjuvant atorvastatin improves frequency domain indices of heart rate variability in stable systolic heart failure.
Ali Hamaad, Mike Sosin, Gregory Y H Lip, Robert J MacFadyen. Cardiovasc Drugs Ther 2005
35
28

Effect of atorvastatin and fenofibrate on autonomic tone in subjects with combined hyperlipidemia.
Vojtech Melenovsky, Dan Wichterle, Jan Simek, Jan Malik, Tomas Haas, Richard Ceska, Marek Malik. Am J Cardiol 2003
23
43

Heart rate variability and progression of coronary atherosclerosis.
H V Huikuri, V Jokinen, M Syvänne, M S Nieminen, K E Airaksinen, M J Ikäheimo, J M Koistinen, H Kauma, A Y Kesäniemi, S Majahalme,[...]. Arterioscler Thromb Vasc Biol 1999
197
10


The effect of statin therapy on ventricular late potentials in acute myocardial infarction.
Meral Kayikcioglu, Levent Can, Harun Evrengul, Serdar Payzin, Hakan Kultursay. Int J Cardiol 2003
37
24

Simvastatin therapy normalizes sympathetic neural control in experimental heart failure: roles of angiotensin II type 1 receptors and NAD(P)H oxidase.
Lie Gao, Wei Wang, Yu-Long Li, Harold D Schultz, Dongmei Liu, Kurtis G Cornish, Irving H Zucker. Circulation 2005
115
10


Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial.
Luigi Tavazzi, Aldo P Maggioni, Roberto Marchioli, Simona Barlera, Maria Grazia Franzosi, Roberto Latini, Donata Lucci, Gian Luigi Nicolosi, Maurizio Porcu, Gianni Tognoni. Lancet 2008
715
10




Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial.
G G Schwartz, A G Olsson, M D Ezekowitz, P Ganz, M F Oliver, D Waters, A Zeiher, B R Chaitman, S Leslie, T Stern. JAMA 2001
9

Intensive lipid lowering with atorvastatin in patients with stable coronary disease.
John C LaRosa, Scott M Grundy, David D Waters, Charles Shear, Philip Barter, Jean-Charles Fruchart, Antonio M Gotto, Heiner Greten, John J P Kastelein, James Shepherd,[...]. N Engl J Med 2005
9

The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals.
Y Kureishi, Z Luo, I Shiojima, A Bialik, D Fulton, D J Lefer, W C Sessa, K Walsh. Nat Med 2000
7





Pravastatin prevents arrhythmias induced by coronary artery ischemia/reperfusion in anesthetized normocholesterolemic rats.
Jianguang Chen, Yoshinobu Nagasawa, Bing-Mei Zhu, Masami Ohmori, Ken-ichi Harada, Akio Fujimura, Keitaro Hashimoto. J Pharmacol Sci 2003
42
16

Statin therapy is associated with improved survival in ischemic and non-ischemic heart failure.
Tamara B Horwich, W Robb MacLellan, Gregg C Fonarow. J Am Coll Cardiol 2004
263
7

Effect of statin use within the first 24 hours of admission for acute myocardial infarction on early morbidity and mortality.
Gregg C Fonarow, R Scott Wright, Frederick A Spencer, Paul D Fredrick, Wei Dong, Nathan Every, William J French. Am J Cardiol 2005
181
7

Atorvastatin improves left ventricular systolic function and serum markers of inflammation in nonischemic heart failure.
Srikanth Sola, Muhammad Q S Mir, Stamatios Lerakis, Neeraj Tandon, Bobby V Khan. J Am Coll Cardiol 2006
250
7

Effect of statin therapy on risk of ventricular arrhythmia among patients with coronary artery disease and an implantable cardioverter-defibrillator.
John H Chiu, Raed H Abdelhadi, Mina K Chung, Hitinder S Gurm, Nassir F Marrouche, Walid I Saliba, Andrea Natale, David O Martin. Am J Cardiol 2005
52
13


The effects of simvastatin on the incidence of heart failure in patients with coronary heart disease.
J Kjekshus, T R Pedersen, A G Olsson, O Faergeman, K Pyörälä. J Card Fail 1997
260
6

Statin-sensitive dysregulated AT1 receptor function and density in hypercholesterolemic men.
G Nickenig, A T Bäumer, Y Temur, D Kebben, F Jockenhövel, M Böhm. Circulation 1999
325
6


Simvastatin upregulates coronary vascular endothelial nitric oxide production in conscious dogs.
S Mital, X Zhang, G Zhao, R D Bernstein, C J Smith, D L Fulton, W C Sessa, J K Liao, T H Hintze. Am J Physiol Heart Circ Physiol 2000
88
6


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.